Detalhe da pesquisa
1.
E2F7 promotes mammalian target of rapamycin inhibitor resistance in hepatocellular carcinoma after liver transplantation.
Am J Transplant
; 22(10): 2323-2336, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35729702
2.
USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation.
Gut
; 69(7): 1322-1334, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31776228
3.
Hangzhou criteria as downstaging criteria in hepatocellular carcinoma before liver transplantation: A multicenter study from China.
Hepatobiliary Pancreat Dis Int
; 19(4): 349-357, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32622826
4.
Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
Mol Cancer
; 18(1): 114, 2019 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31269959
5.
Metallothionein 1 family profiling identifies MT1X as a tumor suppressor involved in the progression and metastastatic capacity of hepatocellular carcinoma.
Mol Carcinog
; 57(11): 1435-1444, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29873415
6.
Crosstalk between cancer-associated fibroblasts and regulated cell death in tumors: insights into apoptosis, autophagy, ferroptosis, and pyroptosis.
Cell Death Discov
; 10(1): 189, 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38649701
7.
Ubiquitin-specific protease 22 promotes tumorigenesis and progression by an FKBP12/mTORC1/autophagy positive feedback loop in hepatocellular carcinoma.
MedComm (2020)
; 4(6): e439, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38045832
8.
Targeting pyroptosis in breast cancer: biological functions and therapeutic potentials on It.
Cell Death Discov
; 9(1): 75, 2023 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36823153
9.
Sirolimus-based immunosuppression improves the prognosis of liver Transplantation Recipients with low TSC1/2 expression in hepatocellular carcinoma beyond the Milan Criteria.
Eur J Surg Oncol
; 47(10): 2533-2542, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33902956
10.
Self-Activated Cascade-Responsive Sorafenib and USP22 shRNA Co-Delivery System for Synergetic Hepatocellular Carcinoma Therapy.
Adv Sci (Weinh)
; 8(5): 2003042, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33717848
11.
"Sweet tooth"-oriented SN38 prodrug delivery nanoplatform for targeted gastric cancer therapy.
J Mater Chem B
; 9(12): 2816-2830, 2021 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33690741
12.
Sirolimus-based immunosuppression improves outcomes in liver transplantation recipients with hepatocellular carcinoma beyond the Hangzhou criteria.
Ann Transl Med
; 8(4): 80, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32175373
13.
High Expression of Human AugminComplex Submit 3 Indicates Poor Prognosis and Associates with Tumor Progression in Hepatocellular Carcinoma.
J Cancer
; 10(6): 1434-1443, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31031853